Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers.

Autor: Joosten, S. C.^1,2 (AUTHOR), Odeh, S. N. O.¹ (AUTHOR), Koch, A.¹ (AUTHOR), Buekers, N.¹ (AUTHOR), Aarts, M. J. B.² (AUTHOR), Baldewijns, M. M. L. L.³ (AUTHOR), Van Neste, L.¹ (AUTHOR), van Kuijk, S.⁴ (AUTHOR), Schouten, L. J.⁵ (AUTHOR), van den Brandt, P. A.⁵ (AUTHOR), Tjan-Heijnen, V. C.² (AUTHOR), van Engeland, M.¹ (AUTHOR), Smits, K. M.¹ (AUTHOR) kim.smits@maastrichtuniversity.nl

Publikováno v: Clinical Epigenetics. 5/4/2021, Vol. 13 Issue 1, p1-11. 11p.